Investment – by July 2005
|Indonesia Pharmaceutical Published by Pacific Bridge Medical By Ames Gross and Rachel Weintraub July 2005 The pharmaceutical market in Indonesia is currently valued at around $350 million. More than 50 percent of the market is comprised of imported products, with a large portion coming from the U.S., Germany, Switzerland and Japan. Foreign companies importing finished products or raw materials into Indonesia are required to obtain an import license from the Ministry of Health. The National Agency of Drug and Food Control (NA-DFC) is responsible for ensuring the safety, quality and efficacy of pharmaceuticals in Indonesia. The NA-DFC also handles the drug application review process and grants drug approvals in the form of a marketing authorization license|
No comments yet.
- Apotek Belum Pasang Harga Obat di Kemasan
- Drug labeling implemented in stops and starts
- Dokter berdagang obat, bukan hanya menyembuhkan
- Harga Eceran Tertinggi: Seperti apa aplikasinya?
- RI pharmaceutical industry statistics (in Rp trillion)
- Standarisasi Mutu Obat Generik Menjelang 2008
- So Expensive..Why?
- Pill-popping public ‘victims of unregulated market’
- Investment – by July 2005
- Harga Obat-obatan Bermerek Turun
- Harga Obat Generik Bermerek Akan Diturunkan
- Pharmacy industry needs to increase R&D spending